Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

View source ↗

Summary

Clinical trial update for VALID evaluating antibody responses to the measles vaccine in children with Sickle Cell Disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles vaccine (live attenuated) (Measles vaccine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease, Measles Vaccination | Status: RECRUITING